Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma. 2008

N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
Department of Respiratory Medicine, Renmin Hospital of Wuhan University, Wuhan, China. nhxbj@sohu.com

OBJECTIVE A proportion of asthmatic patients can achieve total control according to the Global Initiative for Asthma/National Institute of Health guidelines. The aim of this study was to investigate whether total control of asthma is accompanied by the remission of airway inflammation and bronchial hyperresponsiveness. METHODS We assessed the number of eosinophil and the levels of eosinophil cationic protein (ECP) and interleukin (IL)-5 in induced sputum and bronchial responsiveness to methacholine in 76 patients with totally controlled asthma in comparison with 30 current untreated asthmatics and 20 healthy subjects. RESULTS We found significantly higher number of eosinophil and higher levels of ECP and IL-5 in the total control group than those in healthy subjects (6.9% +/- 3.6% and 1.3% +/- 1.1%, 129.0 +/- 53.8 mug/l and 48.9 +/- 20.4 mug/l, 22.1 +/- 15.2 mug/l and 10.6 +/- 5.2 mug/l, respectively; p < 0.001), but lower than those in current asthma group (16.2% +/- 8.6%, 362.2 +/- 151.6 mug/l, 50.6 +/-25.8 mug/l, respectively; p < 0.001). Sixty-five (85.5%) patients with totally controlled asthma showed positive methacholine challenge test. In the total control group, number of eosinophil and the levels of ECP and IL-5 in induced sputum of patients with negative methacholine challenge test were significantly lower than those in subjects with positive methacholine challenge test (p < 0.001), whereas sputum number of eosinophil and the levels of ECP and IL-5 in patients with negative methacholine challenge test and those of healthy subjects were similar (p > 0.05). CONCLUSIONS The results of this study suggest that airway inflammation and bronchial hyperresponsiveness still persisted during total control of asthma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
May 1998, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
August 2003, Internal medicine (Tokyo, Japan),
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
February 2011, The Journal of allergy and clinical immunology,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
September 2001, The European respiratory journal,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
January 1989, Respiration; international review of thoracic diseases,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
January 1993, Arerugi = [Allergy],
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
September 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
March 2003, Allergy,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
April 2002, Thorax,
N Hanxiang, and Y Jiong, and C Yanwei, and W Dunshuang, and D Xuhong, and W Xiaojun, and L Changsheng
July 1998, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Copied contents to your clipboard!